Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

67%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03799484Phase 4Completed

Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum Ointment

Role: collaborator

NCT02681419Phase 4Terminated

Evaluating the Efficacy of Fenestrations in Tube Shunt Implants During the Early Postoperative Period

Role: collaborator

NCT02837536Not ApplicableCompleted

Horizontal vs. Vertical Positioning of the iCare Rebound Tonometer and Effects on Intraocular Pressure Readings

Role: collaborator

All 3 trials loaded